Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Total Non-Current Assets: $80,489M in FY2025, up 11.0% from a year earlier.
Latest, FY2025
80,489
Period ended Dec 31, 2025
Change on a year earlier
+11.0%
72,542 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below
Where the FY2025 figure comes from
“|| Total non-current assets | 88 402 | 80 489”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Non-Current Assets ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 80,489 | +11.0% | Novartis Form 6-K (0001114448-26-000014) ↗ |
| FY2024 | Dec 31, 2024 | 72,542 | +4.4% | Novartis Form 6-K (0001114448-25-000003) ↗ |
| FY2023 | Dec 31, 2023 | 69,464 | -13.8% | Novartis Form 6-K (0001370368-24-000022) ↗ |
| FY2022 | Dec 31, 2022 | 80,543 | -6.4% | Novartis Form 6-K (0001370368-23-000068) ↗ |
| FY2021 | Dec 31, 2021 | 86,077 | -12.3% | Novartis Form 6-K (0001370368-22-000077) ↗ |
| FY2020 | Dec 31, 2020 | 98,105 | +10.4% | Novartis Form 6-K (0001370368-21-000072) ↗ |
| FY2019 | Dec 31, 2019 | 88,866 | -19.2% | Novartis Form 6-K (0001370368-20-000086) ↗ |
| FY2018 | Dec 31, 2018 | 110,000 | – | Novartis Form 6-K (0001370368-19-000062) ↗ |
Cite this data
StockData. (2026). Novartis Total Non-Current Assets ($M), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-noncurr-assets
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.